Novavax Inc (WBO:NVAX)
€ 9.276 -0.09 (-0.96%) Market Cap: 1.49 Bil Enterprise Value: 734.28 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 47/100

Novavax Inc To Host Conference Call Transcript

Feb 10, 2022 / 09:30PM GMT
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the call on the results from the pediatric expansion of the Novavax PREVENT-19 pivotal Phase III trial. (Operator Instructions) Please be advised that today's conference call is being recorded, but the recording will not be publicly distributed.

I would now like to turn the conference over to Silvia Taylor, Senior Vice President of Global Corporate Affairs. You may begin.

Silvia Taylor
Novavax, Inc. - SVP of Global Corporate Affairs & IR

Good evening, everyone, and thank you to all of you who have joined today's call. We're delighted to share with you today the results from the adolescent portion of our PREVENT-19 pivotal Phase III trial. A press release announcing our results is currently available on our website at novavax.com, and an audio archive of this conference call will be available on our website later today. Please also note that we have posted the slides that we are us

ing during this evening's call at novavax.com/events.

Joining me today for discussion

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot